FIBROBIOLOGICS, INC. COMMON STOCK

NASDAQ: FBLG (FibroBiologics, Inc.)

Last update: 1 hour ago

0.980

0.02 (2.06%)

Previous Close 0.960
Volume 41,010
Price / Book 1.27
52 Weeks Range
0.620 (-36%) — 9.60 (879%)
Diluted EPS (TTM) -0.210
Total Debt/Equity (MRQ) 302.81%
Current Ratio (MRQ) 1.14
Operating Cash Flow (TTM) -12.90 M
Levered Free Cash Flow (TTM) -17.74 M
Return on Assets (TTM) -81.15%
Return on Equity (TTM) -559.73%

Market Trend

Short Term Medium Term
Industry Biotechnology (US) Mixed Bullish
Biotechnology (Global) Mixed Bullish
Stock FibroBiologics, Inc. Mixed Bearish

AIStockmoo Score

-2.6
Value 35% -4.4
AI Insight info NA
Relative Valuation info NA
Financial Health info -4.4
Timing 35% -0.5
AI Technical info NA
Technical Oscillators info -2.5
Technical Moving Averages info 2.5
Smart Money 30% 0.0
Analyst Consensus info 0.0
Insider Activity info NA
Environment ×1.21
Macro Environment info -3.3
Sector vs Market (6M) -36.3%
Pillar Agreement ×1.25
Not in score
Price Volatility info 0.1
Final Score -2.60

Similar Stocks

Stock Market Cap DY P/E (TTM) P/B
FBLG - - - 1.27
FOLD 5 B - - -
IGMS 71 M - - 0.760
CADL - - - 5.46
KRYS - - - 6.42
ACAD - - - 2.83

Select this tab to load the latest available analysis.

FibroBiologics Inc a clinical-stage biotechnology company focused on developing and commercializing fibroblast-based therapies for patients suffering from chronic diseases with unmet medical needs, including wound healing, multiple sclerosis, or MS, degenerative disc disease, psoriasis, certain cancers, and potential human longevity applications including thymic involution reversal using a thymic organoid. Its product candidates are CYWC628, CYPS317, CYMS101 and CybroCell.

Sector Healthcare
Industry Biotechnology
Investment Style Small Growth
% Held by Insiders 21.42%
% Held by Institutions 16.75%

Ownership

Name Date Shares Held
Cascade Financial Partners, Llc 30 Jun 2026 108,828
Ifp Advisors, Inc 30 Sep 2026 27,000
Qube Research & Technologies Ltd 30 Jun 2026 24,313
Grove Bank & Trust 30 Sep 2026 100
Bfc Planning, Inc. 30 Jun 2026 50

No data within this time range.

Portfolio

AI Template

Your price alert

Risk Profile

| | | | |
Conservative
Moderate Conservative
Moderate
Moderate Aggressive
Aggressive
Margin of Safety (EP)
Partial Profit (TP1)
Target Profit (TP2)
Maximum Loss (SL)

Disclaimer: The above is for illustrative purposes only and is NOT investment advice. Seek advice from a qualified financial professional.

Entry Price (EP)

Take Profit 1 (TP1)

Take Profit 2 (TP2)

Stop Loss (SL)

52W Range
 
52WL
 
52WH
SL
EP
TP1
TP2

All alert prices are within 52 weeks price range

Realized Profit -
Unrealized Profit -
Dividend Received 2026 -
Total Profit -
Avg. Return -
Quantity (Buy) -
Avg. Price (Buy) -
Quantity (Sold) -
Avg. Price (Sold) -
No stocks matching your criteria